KAILERA
Live / Allowed — First extension granted (statement of use) (as of 10 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Sept 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98773333
- Mark type
- Stylized text
- Filed
- 27 Sept 2024
- Published for opposition
- 18 Nov 2025
- Attorney of record
- Gabriel M. Gillmeyer
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of metabolic and endocrine diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the fields of metabolic science and endocrine science
Owner
- Kailera Therapeutics, Inc., Waltham, MA, US
- Kailera Therapeutics, Inc., Waltham, MA, US
Board proceedings on this mark
- Extension of Time to Oppose No. 98773333 — Kymera Therapeutics, Inc. v. Kailera Therapeutics, Inc., filed 16 Dec 2025 (Terminated)
Prosecution history
- 10 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Aug 2026 — SOU EXTENSION 1 GRANTED
- 10 Aug 2026 — SOU EXTENSION 1 FILED
- 10 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Jul 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Jul 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Jul 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jan 2026 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 20 Jan 2026 — CASE ASSIGNED TO TTAB
- 20 Jan 2026 — NOTICE OF ALLOWANCE CANCELLED
- 13 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Dec 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Nov 2025 — PUBLISHED FOR OPPOSITION